Monday - Friday:
9:00am - 5:00pm (EST)
The US Food and Drug Administration (FDA) has approved a new oral formulation of deferasirox. The tablet will be marketed as Jadenu by Novartis, who also market Exjade, which has been the standard deferasirox formulation for the past 10 years.
FENDI presents the 3Baguette charity project in collaboration with the SCDAA's very own parent ambassador & model Jourdan Dunn, who has been invited by FENDI to personalize their own 3Baguette bag, allowing for a completely unique and fully interpreted creation that will be auctioned to benefit sickle cell disease!
Sickle Cell Disease Association of America, Inc.
231 E. Baltimore Street,
Baltimore, MD 21202
Toll Free 800.421.8453